2020
DOI: 10.1002/dmrr.3400
|View full text |Cite
|
Sign up to set email alerts
|

PDX1/NKX6.1+ progenitors derived from human pluripotent stem cells as a novel source of insulin‐secreting cells

Abstract: Aim Beta cell replacement strategies are a promising alternative for diabetes treatment. Human pluripotent stem cells (hPSCs) serve as a scalable source for producing insulin‐secreting cells for transplantation therapy. We recently generated novel hPSC‐derived pancreatic progenitors, expressing high levels of the transcription factor NKX6.1, in the absence of PDX1 (PDX1−/NKX6.1+). Herein, our aim was to characterize this novel population and assess its ability to differentiate into insulin‐secreting beta cells… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 22 publications
(11 citation statements)
references
References 51 publications
0
11
0
Order By: Relevance
“…With combinations of signaling pathway regulators for later step, eventually resulting in the generation of β cells with high efficiency (Liu et al, 2021 ). Intriguingly, a novel population of pancreatic progenitors expressing NKX6-1 but not PDX1 has been identified during in vitro pancreatic differentiation from human PSCs (Memon et al, 2018 ; Aigha et al, 2018 ), which can further differentiate into glucose-responsive INS-positive β cells in vitro (Memon et al, 2021 ). These PDX1-negative/NKX6-1-positive cells are non-epithelial with high expression of NESTIN but lacking the pancreatic epithelial marker CDH1, and similar to progenitor cells resident in the pancreatic mesenchyme, indicating that there is an alternative β cell determination route distinct from that of the PDX1 and NKX6-1 co-expressing progenitors during development (Memon et al, 2021 ).…”
Section: Specialization Into Pancreatic Progenitor Cellsmentioning
confidence: 99%
“…With combinations of signaling pathway regulators for later step, eventually resulting in the generation of β cells with high efficiency (Liu et al, 2021 ). Intriguingly, a novel population of pancreatic progenitors expressing NKX6-1 but not PDX1 has been identified during in vitro pancreatic differentiation from human PSCs (Memon et al, 2018 ; Aigha et al, 2018 ), which can further differentiate into glucose-responsive INS-positive β cells in vitro (Memon et al, 2021 ). These PDX1-negative/NKX6-1-positive cells are non-epithelial with high expression of NESTIN but lacking the pancreatic epithelial marker CDH1, and similar to progenitor cells resident in the pancreatic mesenchyme, indicating that there is an alternative β cell determination route distinct from that of the PDX1 and NKX6-1 co-expressing progenitors during development (Memon et al, 2021 ).…”
Section: Specialization Into Pancreatic Progenitor Cellsmentioning
confidence: 99%
“…centage of PDX1 + and PDX1 + /NKX 6.1 + target cells in a confluent monolayer and minimized commitment to alternate lineages (Figure 4). [46] This strategy provides important insights into the transcriptional programs that tightly regulate this process. This further suggests that HA induces synchronous EMT-MET, thereby homogenizing the cell response to differentiation factors supplemented in the differentiation medium and consequently increasing the reproducibility of the culture.…”
Section: Discussionmentioning
confidence: 99%
“…Immunocytochemistry was performed as we previously reported [ 44 , 46 ]. Cells were washed with DPBS (ThermoFisher Scientific) and fixed with 4% PFA (Sigma–Aldrich) at room temperature for 20 min, followed by washes with tris-buffered saline containing 0.5% Tween-20 (TBST) (Sigma–Aldrich) twice and permeabilized using phosphate buffered saline with 0.5% Triton (PBST) (Sigma–Aldrich) at room temperature for 20 mins.…”
Section: Methodsmentioning
confidence: 99%